Bioscan Research Raises $1 Million To Expand AI-Powered Brain Diagnostics

MedTech startup Bioscan Research has raised $1 million in a seed funding round led by Unicorn India Ventures to expand its non-invasive brain injury detection technology.

The funding will support market expansion, additional regulatory approvals, product enhancements, and the development of new intellectual property as the company prepares for its next phase of growth.

Bringing AI Into Emergency Diagnostics

Founded in 2017 by Anupam Lavania and Shilpa Malik, Bioscan Research develops medical devices that combine optics, electronics, precision engineering, software, and machine learning to detect critical conditions without invasive procedures.

Its flagship product, CEREBO, is a machine learning-powered Near Infrared Spectroscopy (NIRS) device designed to help clinicians identify intracranial injuries in trauma patients, including cases where symptoms may not yet be visible. The company says the device aims to support faster clinical assessment during the critical "golden period" following a brain injury.

The funding comes as healthcare providers increasingly look...

Copyright of this story solely belongs to ciol.com. To see the full text click HERE